ArticleInvestigational new drugs2020

Phase I study of the anti-heparin-binding epidermal growth factor-like growth factor antibody U3-1565 with cetuximab in patients with cetuximab- or panitumumab-resistant metastatic colorectal cancer.

Takako Eguchi Nakajima et al.PubMed ↗Publisher ↗

No numbers read from the abstract.